Industry
Pharmaceuticals
Model
Services
CHALLENGE
Pharmaceutical Innovation to Market
Introducing a new dosage form requires precision. Scienture turned to Responsory to build their market presence, resulting in a compliance-first digital launch that supported commercial sales and set a new go-to-market standard.
Scienture, LLC faced the complex challenge of launching Arbli™ (losartan potassium) 10 mg/mL oral suspension—the first and only FDA-approved liquid losartan formulation. The pharmaceutical startup needed to establish market presence for a breakthrough product addressing a critical unmet need: hypertension treatment for patients who cannot swallow tablets.
Key Challenges:
- Market Education: Healthcare providers were unfamiliar with the availability of a liquid losartan option, relying instead on inconsistent compounded alternatives
- Multi-Audience Complexity: Campaign needed to effectively reach geriatricians, pediatricians, family medicine physicians, pharmacists, patients, and caregivers
- Regulatory Compliance: All marketing materials required strict adherence to FDA pharmaceutical advertising guidelines
- Competitive Positioning: Differentiate against established tablet losartan in a $292 million market with 68 million annual prescriptions
SOLUTION
Integrated Marketing Strategy with Evidence-Based Messaging
Responsory developed a comprehensive go-to-market strategy targeting healthcare professionals as the primary audience while building patient and caregiver awareness through multiple touchpoints.
The Arbli website was designed as the cornerstone of a full commercial launch strategy for the first FDA-approved liquid losartan. Every page and pathway was planned around its key audiences — patients, caregivers, prescribers, and pharmacists — ensuring that each experiences content tailored to their needs while staying aligned with Medical, Legal, and Regulatory (MLR) standards.
More from this project
Website Walkthrough
Launching a new drug takes more than a great product — it requires a digital ecosystem built to inform, engage, and comply.
This two-minute video showcases how Responsory’s pharma marketing, UX design, and content strategy teams collaborated to deliver a compliant, audience-first website experience. From adaptive safety information and accessibility features to conversion-driven resources and intuitive navigation, the Arbli site demonstrates how a well-orchestrated digital hub can educate, engage, and drive confidence across all stakeholders in a brand’s launch.
Results
Successful Market Entry and Commercial Launch
The multichannel marketing campaign successfully positioned Arbli™ for commercial success, achieving key launch objectives:
Market Positioning:
- Established Arbli™ as the definitive liquid losartan solution in healthcare provider minds
- Successfully differentiated from compounded alternatives through FDA approval messaging
- Created strong brand recognition within target physician specialties
Digital Preparedness:
- On-time marketing launch coincided with product availability for commercial sales and fulfillment
- Earned excellent SEO performance for arbli.com out of the gate, ranking highly for relevant key search terms
- Developed creative strategy and campaign-ready assets for native and display advertising designed to engage key healthcare professional audiences
- Produced public relations and social media assets strategically designed to amplify campaign reach and engagement across channels
“Working with Responsory was one of the best decisions we made for our business. From the very first meeting, the team understood our new product launch goals and brought clarity, creativity and efficiency to our strategy.
Our product brand now has a unique position in the market, brought to life by beautifully curated visuals and spot-on messaging. We are now well-positioned for our emerging company’s first successful product launch.”
Michele Rath, SVP and Chief Commercial Officer, Scienture, LLC
